FDA 483 - Cardinal Health 414, LLC - September 12, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Cardinal Health 414, LLC in Indianapolis, IN, revealed significant deficiencies in quality control and facility maintenance. The firm failed to thoroughly investigate out-of-specification results and microbial contamination, and its sampling methods for bioburden testing were found to be unrepresentative. Additionally, critical production line equipment was damaged and lacked proper repair documentation, indicating a risk to drug product quality and safety.
ID · b19c8f0a-7db6-4063-9417-a60a4caceb87